Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project by Alberto Piperno, Stefania.

Slides:



Advertisements
Similar presentations
به نام یگانه هستی بخش. MODERN INSIGHTS INTO ANEMIA.
Advertisements

Glucose metabolism impacts the spatiotemporal onset and magnitude of HSC induction in vivo by James M. Harris, Virginie Esain, Gregory M. Frechette, Lauren.
Transferrin-a modulates hepcidin expression in zebrafish embryos by Paula G. Fraenkel, Yann Gibert, Jason L. Holzheimer, Victoria J. Lattanzi, Sarah F.
Chapter 14: The Cardiovascular System- Blood. Functions of the Blood 1)Transportation -Gases (O 2 and CO 2 ) -Nutrients -Heat and waste -Hormones 2)Regulation.
Transferrin therapy ameliorates disease in β-thalassemic mice Alisha Juman Lakeland High School Grade 10 Li H, Rybicki AC, Suzuka SM, et al. Nat Med
Lecture 2 Red Blood Cells, Anemias & Polycythemias
The graph is based on data submitted to the WHO as of June Global Prevalence of Hepatitis C Virus.
An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe −/− mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.
Iron regulation and determination of iron stores Sean Lynch Eastern Virginia Medical School USA.
Absorption, transport, and storage of iron
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD  Nupur Gupta, MD, Jay B. Wish, MD  American.
Iain C. Macdougall, BSc, MD, FRCP  American Journal of Kidney Diseases 
The influence of high-altitude living on body iron
Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications by Igor Theurl, Elmar Aigner,
by Jane Yui, Choy-Pik Chiu, and Peter M. Lansdorp
Quantitative analysis of murine terminal erythroid differentiation in vivo: novel method to study normal and disordered erythropoiesis by Jing Liu, Jianhua.
by Seth Rivera, Lide Liu, Elizabeta Nemeth, Victoria Gabayan, Ole E
by Dai Chida, Osamu Miura, Akihiko Yoshimura, and Atsushi Miyajima
Pocket-sized iron regulators: one size fits all?
Bulging glands? Blame it on B cells
by Khaled M. Musallam, Vijay G
by Curry L. Koening, Jennifer C. Miller, Jenifer M. Nelson, Diane M
Knocking out the PCFT by Donald W. Jacobsen Blood
In utero transplantation may soon be in delivery
New options for the anemia of chronic kidney disease
Hepcidin in human iron disorders: Therapeutic implications
by Malte Peters, Albrecht M. Müller, and Stefan Rose-John
by Gail Dallalio, Erin Law, and Robert T. Means
Homozygous deletion of HFE: the Sardinian hemochromatosis?
SOX11 holds mantle cell lymphoma’s key to home
Hypoxia-Inducible Factors Link Iron Homeostasis and Erythropoiesis
Low hepcidin accounts for the proinflammatory status associated with iron deficiency by Alessia Pagani, Antonella Nai, Gianfranca Corna, Lidia Bosurgi,
Polycythemia vera following autologous transplantation for AML: insights on the kinetics of JAK2V617F clonal dominance by Elisabetta Antonioli, Paola Guglielmelli,
Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator by Yan Jiao, John Wilkinson, Xiumin Di, Wei Wang,
Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo by Ying Liu, Ramona.
by Natalie J. Foot, Yew Ann Leong, Loretta E. Dorstyn, Hazel E
by James D. Cook, Carol H. Flowers, and Barry S. Skikne
by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle
Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response by Fotios P. Panitsas, Maria Theodoropoulou,
Patients’ priorities in selecting chronic lymphocytic leukemia treatments by Carol Mansfield, Anthony Masaquel, Jessie Sutphin, Elisa Weiss, Meghan Gutierrez,
Disruption of Iron Regulation after Radiation and Donor Cell Infusion
Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia by Shannon L. Maude, Sibasish.
by Vladia Monsurrò, Ena Wang, Yoshisha Yamano, Stephen A
Anergy: the CLL cell limbo
Volume 86, Issue 6, Pages (December 2014)
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD  Nupur Gupta, MD, Jay B. Wish, MD  American.
Complete remission through blast cell differentiation inPLZF/RARα-positive acute promyelocytic leukemia: in vitro and in vivo studies by Maria C. Petti,
The second transferrin receptor regulates red blood cell production in mice by Antonella Nai, Maria Rosa Lidonnici, Marco Rausa, Giacomo Mandelli, Alessia.
Ironing out Ferroportin
59Fe-distribution in conditional ferritin-H–deleted mice
Reciprocal regulation between hepcidin and erythropoiesis and its therapeutic application in erythroid disorders  Caiyi Wang, Zheng Fang, Zesen Zhu, Jing.
Comparison of cytokine profiles induced by ChiLob 7/4 and TLR ligands in ex vivo whole-blood stimulation assays. Comparison of cytokine profiles induced.
Male patient of 52 years old with a two-year history of fatigue and pruritus of his legs , headache . And visual disturbances . He smoked one pack of.
Effects of Daprodustat, a Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Anemia Management in Japanese Hemodialysis Subjects Akizawa et.
STAT3-dependent IL-21 production from T helper cells regulates hematopoietic progenitor cell homeostasis by Mark H. Kaplan, Nicole L. Glosson, Gretta L.
Balancing Acts Cell Volume 117, Issue 3, Pages (April 2004)
Volume 78, Issue 7, Pages (October 2010)
Molecular Pathophysiology of Iron Disorders
A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia by Lili Aslostovar, Allison L. Boyd, Mohammed.
Erythropoietin and iron
Cellular iron: Ferroportin is the only way out
Cellular iron metabolism
A specialized pathway for erythroid iron delivery through lysosomal trafficking of transferrin receptor 2 by Shadi Khalil, Maja Holy, Stephen Grado, Robert.
Niels Grote Beverborg et al. JCHF 2018;6:
Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.
Unexpected role of ceruloplasmin in intestinal iron absorption
Schematic representation of the mechanisms underlying anemia of CKD
O2 Sensing: Only Skin Deep?
Hepcidin: clinical utility as a diagnostic tool and therapeutic target
Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non–transferrin-bound iron by Eldad.
Presentation transcript:

Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project by Alberto Piperno, Stefania Galimberti, Raffaella Mariani, Sara Pelucchi, Giulia Ravasi, Carolina Lombardi, Grzegorz Bilo, Miriam Revera, Andrea Giuliano, Andrea Faini, Veronica Mainini, Mark Westerman, Tomas Ganz, Maria Grazia Valsecchi, Giuseppe Mancia, Gianfranco Parati, and Blood Volume 117(10):2953-2959 March 10, 2011 ©2011 by American Society of Hematology

Time course of the HIGHCARE project: altitude, locations, means of transportation between locations, days of ascent, staying and descent, and blood sampling. Time course of the HIGHCARE project: altitude, locations, means of transportation between locations, days of ascent, staying and descent, and blood sampling. Alberto Piperno et al. Blood 2011;117:2953-2959 ©2011 by American Society of Hematology

Longitudinal profiles of the relevant parameters at different altitudes. Longitudinal profiles of the relevant parameters at different altitudes. Data are expressed in terms of geometric means and 95% confidence intervals (vertical lines), by sex, and overall. Significant comparison with baseline: **P < .0001; *P < .006. Two subjects were excluded from the analysis of hepcidin and IL-6 because of upper airway infection. Alberto Piperno et al. Blood 2011;117:2953-2959 ©2011 by American Society of Hematology

Hypoxia-induced modifications of iron homeostasis. Hypoxia-induced modifications of iron homeostasis. Erythropoietin (EPO) activation is the first event occurring after acute hypoxia exposure, inducing erythropoietic expansion, which requires more iron for red blood cell hemoglobinization. Hepcidin down-regulation is central for this function: it begins within 16 to 40 hours and peaks within a few days of exposure, and thereafter persists for a long time. Iron and erythroid signals cooperate in hepcidin suppression, increasing intestinal iron absorption and cellular iron release. Iron mobilization from stores occurs early, possibly involving a hypoxia-mediated event. Erythroid signal probably requires soluble mediators from bone marrow to the liver. Transferrin saturation (TS) decreased only in the phase of expansion of the erythropoietic mass contributing to hepcidin suppression. Alberto Piperno et al. Blood 2011;117:2953-2959 ©2011 by American Society of Hematology